Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system.

[1]  J. Ozer,et al.  Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  K. Verhoeckx,et al.  Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  M. Seierstad,et al.  Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors. , 2008, Journal of medicinal chemistry.

[4]  Michael Stavri,et al.  Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. , 2008, Journal of natural products.

[5]  D. Centonze,et al.  The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. , 2008, Current pharmaceutical design.

[6]  M. Maccarrone,et al.  FAAH and anandamide: is 2-AG really the odd one out? , 2008, Trends in pharmacological sciences.

[7]  V. Marzo,et al.  Targeting the endocannabinoid system: to enhance or reduce? , 2008, Nature Reviews Drug Discovery.

[8]  L. Marnett,et al.  Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids* , 2008, Journal of Biological Chemistry.

[9]  D. Centonze,et al.  Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum , 2008, Nature Neuroscience.

[10]  Marco Pierini,et al.  “Quasi flexible” automatic docking processing for studying stereoselective recognition mechanisms, part 2: Prediction of ΔΔG of complexation and 1H‐NMR NOE correlation , 2007, J. Comput. Chem..

[11]  J. Koča,et al.  CAVER: a new tool to explore routes from protein clefts, pockets and cavities , 2006, BMC Bioinformatics.

[12]  M. Maccarrone.  Fatty acid amide hydrolase: a potential target for next generation therapeutics. , 2006, Current pharmaceutical design.

[13]  E. Dainese,et al.  Partial QSAR analysis of some selected natural inhibitors of FAAH suggests a working hypothesis for the development of endocannabinoid-based drugs. , 2005, Current drug targets. CNS and neurological disorders.

[14]  B. Barboni,et al.  Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction , 2005, Journal of Cell Science.

[15]  B. Cravatt,et al.  Structure and function of fatty acid amide hydrolase. , 2005, Annual review of biochemistry.

[16]  P. Vachette,et al.  Structural stability of soybean lipoxygenase-1 in solution as probed by small angle X-ray scattering. , 2005, Journal of molecular biology.

[17]  F. Fezza,et al.  Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity. , 2005, Analytical biochemistry.

[18]  L. Wessjohann,et al.  A New Type of Floral Oil from Malpighia coccigera (Malpighiaceae) and Chemical Considerations on the Evolution of Oil Flowers , 2004, Chemistry & biodiversity.

[19]  L. Petrocellis,et al.  The endocannabinoid system: a general view and latest additions , 2004, British journal of pharmacology.

[20]  N. Ueda,et al.  Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.

[21]  A. Minassi,et al.  A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. , 2004, Biochemical and biophysical research communications.

[22]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[23]  Gareth Williams,et al.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.

[24]  B. Cravatt,et al.  Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. , 2003, Current opinion in chemical biology.

[25]  M. Mattson.  Methylation and acetylation in nervous system development and neurodegenerative disorders , 2003, Ageing Research Reviews.

[26]  K. Nicolay,et al.  Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil against In Vivo Excitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases , 2003, The Journal of Neuroscience.

[27]  T. Freund,et al.  A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. , 2002, Chemistry and physics of lipids.

[28]  Raymond C Stevens,et al.  Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling , 2002, Science.

[29]  K. Chapman,et al.  N-Acylethanolamines Are Metabolized by Lipoxygenase and Amidohydrolase in Competing Pathways during Cottonseed Imbibition1 , 2002, Plant Physiology.

[30]  A. Finazzi-Agro’,et al.  Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. , 2002, Journal of medicinal chemistry.

[31]  Pierangelo Geppetti,et al.  An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[33]  S. Pongor,et al.  Nerve growth factor‐mediated increases in protein methylation occur predominantly at type I arginine methylation sites and involve protein arginine methyltransferase 1 , 2002, Journal of neuroscience research.

[34]  L. Marnett,et al.  Oxidative metabolism of endocannabinoids. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[35]  D. Deutsch,et al.  The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase* , 2001, The Journal of Biological Chemistry.

[36]  M. Maccarrone,et al.  A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase activity. , 1999, Analytical Biochemistry.

[37]  J. Vliegenthart,et al.  With anandamide as substrate plant 5-lipoxygenases behave like 11-lipoxygenases. , 1998, Biochemical and biophysical research communications.

[38]  J. Falck,et al.  Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. , 1998, Molecular pharmacology.

[39]  D. Deutsch,et al.  2-Arachidonoylglycerol (2-AG) membrane transport: History and outlook , 2008, The AAPS Journal.

[40]  V. Di Marzo,et al.  TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. , 2008, Current pharmaceutical design.

[41]  A. Finazzi-Agro’,et al.  Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol , 2008, Journal of Molecular Medicine.

[42]  F. Fezza,et al.  Methods to assay anandamide hydrolysis and transport in synaptosomes. , 2006, Methods in molecular medicine.

[43]  V. Marzo.  Endocannabinoids: synthesis and degradation. , 2006 .

[44]  M. Maccarrone.  Inhibition of anandamide hydrolysis: cells also know how to do it. , 2004, Trends in molecular medicine.

[45]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .